Real-time enrollment status for this ovarian cancer clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 11:40 AM UTC
| NCT Number | NCT04590326 |
| Recruiting Status | Recruiting |
| Condition | Ovarian Cancer |
| Phase | PHASE1 |
| Target Enrollment | 612 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | August 20, 2026 (1 week ago) |
As of August 31, 2026: Clinical trial NCT04590326 is currently recruiting participants. This phase1 study for ovarian cancer is actively seeking new participants at 13 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04590326 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04590326 was last updated 1 week ago (August 20, 2026). HelloStudys verifies this status automatically.